Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 2/20 | 0.35 |
| ▸ | RXRB | P28702 | 2/20 | 0.35 |
| ▸ | RXRG | P48443 | 2/20 | 0.35 |
| ▸ | RARB | P10826 | 1/20 | 0.35 |
| ▸ | RARG | P13631 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1553747 | 0.83 | HPGD (0.38) | HPGDRXRARXRBRXRGALDH1A1 | |
| SCHEMBL4428057 | 0.82 | OPRM1 (0.31) | OPRM1OPRD1 | |
| SCHEMBL8630154 | 0.80 | HPGD (0.56) | HPGDLMNAL3MBTL1RXRARXRB | |
| SCHEMBL726159 | 0.79 | MEN1 (0.46) | HPGDLMNAALDH1A1TSHRMAPK1 | |
| SCHEMBL1555398 | 0.75 | HPGD (0.38) | HPGDLMNAL3MBTL1RXRARXRB | |
| SCHEMBL1554062 | 0.74 | SRD5A2 (0.49) | HPGDLMNAL3MBTL1ALDH1A1 | |
| SCHEMBL1553692 | 0.74 | HPGD (0.61) | HPGDLMNAL3MBTL1ALDH1A1MAPK1 | |
| SCHEMBL4611297 | 0.71 | GSK3B (0.51) | HPGDLMNAL3MBTL1ALDH1A1MAPK1 | |
| SCHEMBL1446377 | 0.70 | AKR1C1 (0.42) | HPGDLMNAALDH1A1TSHR | |
| SCHEMBL727190 | 0.69 | HTT (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1670740-B1 | CLEAR PHOTOPOLYMERIZABLE SYSTEMS FOR THE PREPARATION OF HIGH THICKNESS COATINGS | LAMBERTI SPA (IT) | 2011-04-27 | — | — | EP | disclosed |
| US-7534880-B2 | Clear photopolymerizable systems for the preparation of high thickness coatings | LAMBERTI SPA (IT) | 2009-05-19 | — | — | US | disclosed |
| US-20060246228-A1 | Clear photopolymerizable systems for the preparation of high thickness coatings | LAMBERTI SPA (IT) | 2006-11-02 | — | — | US | disclosed |
| EP-1670740-A2 | CLEAR PHOTOPOLYMERIZABLE SYSTEMS FOR THE PREPARATION OF HIGH THICKNESS COATINGS | Lamberti Spa (IT) | 2006-06-21 | — | — | EP | disclosed |
| WO-2005014515-A2 | CLEAR PHOTOPOLYMERIZABLE SYSTEMS FOR THE PREPARATION OF HIGH THICKNESS COATINGS | LAMBERTI SPA (IT) | 2005-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060246228-A1 | Clear photopolymerizable systems for the preparation of high thickness coatings | CDH1, CLTA, VCL | HPGD 3253/4885LMNA 1005/4885L3MBTL1 4802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.